Repaglinide: A Viewpoint by Bruce H.R. Wolffenbuttel

ISSN： 1170-229X

Source： Drugs & Aging, Vol.13, Iss.2, 1998-08, pp. : 181-181

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Repaglinide

By Balfour J.A. Faulds D.

Drugs & Aging, Vol. 13, Iss. 2, 1998-08 ,pp. : 173-180

Adis International

Access to resources Recommend Favorite

Gabapentin: A Viewpoint by Brett R. Stacey

By Stacey B.R.

CNS Drugs, Vol. 17, Iss. 13, 2003-01 ,pp. : 983-984

Adis International

Access to resources Recommend Favorite

Lubiprostone: A Viewpoint by Lawrence R. Schiller

By Schiller Lawrence R.

Drugs, Vol. 66, Iss. 6, 2006-01 ,pp. : 880-881

Adis International

Access to resources Recommend Favorite

Losartan: A Viewpoint by Donald R. Studney

By Studney D.R.

Drugs, Vol. 63, Iss. 4, 2003-01 ,pp. : 415-416

Adis International

Access to resources Recommend Favorite

Pioglitazone: A Viewpoint by John R. Petrie

By Petrie J.R.

Drugs, Vol. 60, Iss. 2, 2000-08 ,pp. : 344-345

Adis International

Access to resources Recommend Favorite